Atlas Trials

Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.

Clinical trial NCT00750360 · COMPLETED

Trial details

NCT number
NCT00750360
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2003-10-03
Primary completion
2007-12-01
Enrollment
883

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.